People · Operator
Named in public records as an officer, director or promoter · active 2016–2023 · Biotechnology, Other, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tmunity Therapeutics, Inc. | — | Biotechnology | Series C | $175.0M | $3.1B | 2016 |
| Primetime Holdings Inc. | — | Other | Series B | $36.0M | $305.4M | 2023 |
| Scout Bio, Inc. | — | Biotech / Pharma | Series B | $34.0M | $104.3M | 2018 |
Kevin Mahoney at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin Mahoney on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Beth Seidenberg | 1 | 15 |
| Patrick Heron | 1 | 11 |
| Sean Parker | 1 | 10 |
| Patrick Gray | 1 | 10 |
| Herrick Lau | 1 | 10 |
| Judith Li | 1 | 8 |
| John Bell | 1 | 5 |
| Queenie Kuang | 1 | 4 |
| Yan Zhang | 1 | 4 |
| Nancy Hong | 1 | 4 |
| DAVID EATON | 1 | 4 |
| Garry Nicholson | 1 | 3 |
| Roger Dent | 1 | 2 |
| Krishna Polu | 1 | 2 |
| Tadataka Yamada | 1 | 2 |
| GRAEME BELL | 1 | 1 |
| MICHAEL CHRISTIANO | 1 | 1 |
| JIANG ZHANG | 1 | 1 |
| ALESSANDRO RIVA | 1 | 1 |
| Anne Chew | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.